Zurzuvae | FDA approves first postpartum depression pill in the US
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically
(CNN) — The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United
On Friday, the FDA announced that the treatment, to be sold under the brand named Zurzuvae, has been approved as a once-daily pill taken over the course of 14 days.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.